CD&R, McKesson Corporation (NYSE: MCK) ("McKesson"), and Option Care Health, Inc. (Nasdaq: OPCH) ("Option Care Health") announced today that they have entered into a definitive agreement, under which ...

Both funds charge 0.03% and yield roughly 3.8%, but Vanguard manages $51.9 billion in assets versus Schwab's $15.3 billion.

Appearing before SAT in the Jane Street case, Sebi’s counsel argued that the onus was on Jane Street to demonstrate that its trading strategy did not amount to market manipulation.

Regeneron presented new clinical data at ESMO 2026 on Libtayo use in high-risk CSCC and cancer-associated thrombosis.

Forbes examined financial disclosures for every sitting Senator. We found 26 Senators with at least $7 million in investments ...

CSD's concentrated portfolio of 29 holdings, including GEV and HONA, targets operational flexibility. Find out why CSD ETF is ...

Galectin Therapeutics (GALT) stock update: dilution and single-asset risk pressure outlook; belapectin Phase 3 hinges on ...

OPCH and CEG rallied on potential multibillion-dollar agreements, while CTVA gained after a JPMorgan upgrade and NKE fell on a sharp Berenberg downgrade.

PYC Therapeutics shares gained 5.1% as investors looked ahead to clinical data for PYC-003, an experimental RNA treatment for inherited polycystic kidney disease.

US stocks closed higher as Nasdaq hit a record, gaining 1.05%, while Dow rose 91 points. Nvidia and AI stocks led gains ...

Seven semiconductor ETFs holding 18.9 trillion won face index rebalancing on the 8th, concentrating buying demand in chip ...

EHCC trades at about $23.88 and carries an expense ratio of 0.75%. Its trailing distribution yield is roughly 15%, per ...